Drug intelligence / Profile preview

cetirizine + cholecalciferol

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral
01

Overview

**Cetirizine + cholecalciferol** is a non-standardized combination of two active substances: cetirizine, an oral second-generation antihistamine that acts mainly as a selective antagonist at the histamine H1 receptor, and cholecalciferol, also known as vitamin D3, a secosteroid hormone involved in calcium and phosphate homeostasis and bone metabolism. There is limited but emerging clinical evidence that the combination (administered as topical cetirizine plus oral cholecalciferol or both orally) can be used for conditions such as congenital hypotrichosis and allergic rhinitis, especially in patients with vitamin D deficiency[2][5][6].\n\nIn this combination:\n- **Cetirizine** blocks the action of endogenous histamine at the H1 receptor to prevent allergic symptoms such as itching, sneezing, and runny nose.\n- **Cholecalciferol (vitamin D3)** raises serum levels of vitamin D, potentially modulating immune response and inflammation.\n\nThere are no widely recognized proprietary combination products using both active ingredients under a single brand name, and both substances are most often co-administered in clinical practice based on specific therapeutic needs rather than as a fixed-dose combination.

02

Targets

HRH1 (Histamine H1 Receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on cetirizine + cholecalciferol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cetirizine + cholecalciferol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call